AcelRx Pharma (ACRX)

2.80 -0.10 (3.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/9/19 *Est.)

Latest Headlines

Form DEFA14A ACELRX PHARMACEUTICALS May 14, 2019 6:11 AM - SEC Filing Form DEF 14A ACELRX PHARMACEUTICALS For: Jun 25 May 14, 2019 6:10 AM - SEC Filing Form 424B5 ACELRX PHARMACEUTICALS May 9, 2019 8:55 AM - SEC Filing Form 10-Q ACELRX PHARMACEUTICALS For: Mar 31 May 9, 2019 8:53 AM - SEC Filing AcelRx Pharmaceuticals (ACRX) PT Lowered to $6 at RBC Capital May 9, 2019 6:41 AM - StreetInsider Form 8-K ACELRX PHARMACEUTICALS For: May 08 May 8, 2019 4:06 PM - SEC Filing AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results May 8, 2019 4:01 PM - PR NewsWire Form PRE 14A ACELRX PHARMACEUTICALS For: Jun 25 May 3, 2019 5:06 PM - SEC Filing Form 10-K/A ACELRX PHARMACEUTICALS For: Dec 31 April 30, 2019 6:34 AM - SEC Filing AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019 April 25, 2019 4:05 PM - PR NewsWire B.Riley/FBR Starts AcelRx Pharmaceuticals (ACRX) at Buy April 24, 2019 3:33 AM - StreetInsider AcelRx Pharmaceutical's pooled safety results for sufentanil sublingual tablets (DSUVIA) selected for presentation at 44th Annual Regional Anesthesiology & Acute Pain Medicine Meeting April 11, 2019 4:37 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Mar 12 Filed by: EDWARDS MARK G March 12, 2019 2:16 PM - SEC Filing AcelRx Pharmaceuticals to Present at Oppenheimer & Co. Inc. 29th Annual Healthcare Conference March 11, 2019 4:01 PM - PR NewsWire Form S-8 ACELRX PHARMACEUTICALS March 7, 2019 5:58 PM - SEC Filing Form 10-K ACELRX PHARMACEUTICALS For: Dec 31 March 7, 2019 5:27 PM - SEC Filing UPDATE: AcelRx Pharma (ACRX) Announces Commercial Launch of DSUVIA March 7, 2019 4:57 PM - StreetInsider AcelRx Pharma (ACRX) Tops Q4 EPS by 2c March 7, 2019 4:11 PM - StreetInsider Form 8-K ACELRX PHARMACEUTICALS For: Mar 07 March 7, 2019 4:05 PM - SEC Filing AcelRx Pharmaceuticals Announces Commercial Launch of DSUVIA and Reports Fourth Quarter and Full Year 2018 Financial Results March 7, 2019 4:01 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Feb 28 Filed by: ASADORIAN RAFFI March 4, 2019 4:29 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 28 Filed by: Dasu Badri N March 4, 2019 4:28 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 28 Filed by: Angotti Vincent J. March 4, 2019 4:28 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 28 Filed by: Hamel Lawrence G March 4, 2019 4:25 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Feb 28 Filed by: Palmer Pamela P March 4, 2019 4:24 PM - SEC Filing Full Article List